Recent Finacing
Recent Raise
OncoStem Diagnostics develops proteomics- and genomics-based prognostic and predictive diagnostic tests, including CanAssist-Breast for stage 1–3A recurrence risk, and automates assays for multiple cancer types.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors